IJCRR - Vol 08 Issue 12, June, 2016
A DRUG UTILIZATION STUDY OF FIXED DOSE COMBINATIONS USED IN HYPERTENSION IN RURAL TERTIARY HEALTH CARE CENTRE OF CENTRAL INDIA
Author: Shende T.R., Siddiqui R.A., Mahajan H.M.
Hypertension (HTN) accounts for 7.6 million deaths (13–15% of the total) worldwide. The efficacy of antihypertensive agents in lowering blood pressure (BP) and complications of hypertension is well documented. For prime control of BP, two or more antihypertensive agents are required by large number of patients. Aims and Objectives: To analyze the pattern of fixed dose combinations (FDCs) prescribed for treatment of hypertension and blood pressure `control in patients who came to Medicine department of a tertiary care hospital of central India, to get a better perspective in the fallacies and implement improvements to overcome them for better management of hypertension. Material and Methods: The present study was a cross-sectional retrospective record based observational study conducted at Medicine Department of NKP Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital, Nagpur (M.S.). Results: Out of total 164 case records analyzed, 94 (57.3%) were males and 70 (42.6%) were females. Maximum patients belonged to age group >50 years-64 (39%). FDCs were prescribed in 70 patients out of 164 (42.6%), out of which 2 drug FDCs was used most commonly. Overall most commonly prescribed FDC was that of beta blocker (BB) + calcium channel blocker (CCB) used in 23 patients (32.8%), amongst which metoprolol + amlodipine was most commonly prescribed. Conclusion: In the present study physicians preferred monotherapy over FDCs. Such studies should be conducted on timely basis to detect emerging trends in treatment of hypertension, so that health care policies can be planned accordingly.
Keywords: Fixed dose combinations, Antihypertensive agents
Shende T.R., Siddiqui R.A., Mahajan H.M.. A DRUG UTILIZATION STUDY OF FIXED DOSE COMBINATIONS USED IN HYPERTENSION IN RURAL TERTIARY HEALTH CARE CENTRE OF CENTRAL INDIA International Journal of Current Research and Review. Vol 08 Issue 12, June, 30-34
1. Kasper DL, Fauci AS. Hypertensive Vascular Disease. In: Theodore A. Kotchen editor. Harrison’s principles of internal medicine. 19th ed. McGraw Hill Medical NewYork;2015: 1611.
2. Lemogoum D, Seedat YK, Mabadeje AFB, et al. Recommendation for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub Saharan Africa. J Hypertension. 2003; 21: 1993-2000.
3. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control indiverse North American settings. The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens. 2002; 4:339- 40.
4. Olanrewaju TO, Aderibigbe A, Busari OA, et al. Antihypertensive drug utilization and conformity to guidelines in a sub- Saharan African hypertensive population. International Journal of Clinical Pharmacology and Therapeutics 2010; 48(1):68-75.
5. Busari OA, Olarewaju TO, Desalu OO, et al. Impact of knowledge, attitudes and practices on hypertension on compliance with antihypertensive drugs in a resource-poor setting. TAF Preventive Medicine Bulletin 2010; 9(2): 87-92.
6. Monae M, Bohn RL, Gurwitz JH, et al. Th effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in elderly. Am J Hypertens. 1997; 10:697-704.
7. Kapoor B, Raina RK, Kapoor S. Drug prescribing pattern in a teaching hospital. Ind J Pharmacol. 1985;17:168.
8. Pradhan SC, Shewade DG, Shashindran CH, et al. Drug utilization studies. National Med J India. 1988;1:185.
9. Gupta N, Sharma D, Garg SK, et al. Auditing of prescriptions to study utilization of antimicrobials in tertiary hospital. Indian J Pharmacol. 1997;29:411-5.
10. Tahir A, Gulati K, Mohan L, et al. Evaluation of prescribing pattern of fixed dose combination of drugs in outpatients of cardiology in a tertiary care hospital. World Journal of Pharmacy and Pharmaceutical Sciences 2014; 3(11): 625-32.
11. Manjula Devi AS, Sriram S, Rajalingam B, et al. Evaluation of the rationality of fixed dose combinations of cardiovascular drugs in a multispecialty tertiary care hospital in Coimbatore, Tamilnadu, India. Hygeia J D Med. 2012; 4(1): 51-8.
12. Connor J, Rafter N, Rodgers A. Do fixed dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ. 2004; 82(12):935-9.
13. Pan F, Chernew ME, Fendrick AM. Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med. 2008 ; 23(5):611-614.
14. Ekwunife OI, Ubaka CM. Drug utilization of antihypertensive therapy among patients with compelling indications in two hospitals n south-eastern Nigeria. J Pharm Pharmacol Res. 2011 ; 2(1): 25-28.
15. Busari OA, Oluyonbo R, Fasae AJ, et al. Prescribing pattern and utilization of antihypertensive drugs and blood pressure control in adult patients with systemic hypertension in a rural tertiary hospital in Nigeria. Am J Int Med.2014; 2(6): 144-9.
16. Marrick LK, Ronald SF, Michael MM, et al. Short term and long term effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure. Am Heart J. 1999; 138: 261-8.
17. Lacourciere Y, Tytus R, Keefe DO, et al. Efficacy and tolerability of a fixed dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy. Journal of human hypertension. 2001; 15: 763-770.
18. Marc PM, Michel B. Is the fixed dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension Vascular health and risk management. 2007;3(3): 265-278.
19. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52.